Equitec Proprietary Markets, LLC Esperion Therapeutics, Inc. Call Options Transaction History

Equitec Proprietary Markets, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Jul 17, 2018	SELL	$36.2 - $76.4 $3,620 - $7,640	-100 Closed	0 $0
Q1 2018 May 23, 2018	SELL	$65.94 - $80.76 $230,790 - $282,660	-3,500 Reduced 97.22%	100 $7,000
Q4 2017 Jan 24, 2018	SELL	$43.47 - $67.43 $712,908 - $1.11 Million	-16,400 Reduced 82.0%	3,600 $237,000
Q3 2017 Oct 23, 2017	BUY	$43.8 - $52.77 $876,000 - $1.06 Million	20,000	20,000 $1 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.